Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX) is 11% higher in pre-open action Monday after the company said the European Commission ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE